India Guidance Would Make Sponsors Responsible for All Deaths in Trials

Drug Industry Daily
A A
Sponsors of clinical trials in India must begin reporting all deaths that occur “in clinical trials,” under final guidance issued Tuesday by the Central Drugs Standard Control Organization.

To View This Article:

Login

Subscribe To Drug Industry Daily